Genentech, Inc. et al v. InvaGen Pharmaceuticals, Inc., et al.
Plaintiff: Genentech, Inc. and InterMune, Inc.
Defendant: Cipla Limited, InvaGen Pharmaceuticals, Inc. and Cipla USA, Inc.
Case Number: 1:2019cv00219
Filed: February 1, 2019
Court: US District Court for the District of Delaware
Presiding Judge: Richard G Andrews
Nature of Suit: Patent - Abbreviated New Drug Application(ANDA)
Cause of Action: 35 U.S.C. § 271
Jury Demanded By: None
Docket Report

This docket was last retrieved on March 26, 2019. A more recent docket listing may be available from PACER.

Date Filed Document Text
March 26, 2019 Opinion or Order Filing 15 SO ORDERED Granting #14 Stipulation and Order Dismissing Without Prejudice Defendant Cipla Limited and Amending Caption. Signed by Judge Richard G. Andrews on 3/26/2019. (nms)
March 25, 2019 Filing 14 STIPULATION and Proposed Order Dismissing Without Prejudice Defendant Cipla Limited and Amending Caption, by Cipla Limited, Cipla USA, Inc., InvaGen Pharmaceuticals, Inc.. (O'Byrne, Stephanie) Modified on 3/25/2019 (nms).
March 20, 2019 Pro Hac Vice Attorney Nicholas A. Geiger and Steven M. Coyle for Cipla USA, Inc. and InvaGen Pharmaceuticals, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (ceg)
March 19, 2019 Filing 13 MOTION for Pro Hac Vice Appearance of Attorney Steven M. Coyle and Nicholas A. Geiger of Cantor Colburn LLP - filed by Cipla USA, Inc., InvaGen Pharmaceuticals, Inc.. (Palapura, Bindu)
March 19, 2019 Opinion or Order SO ORDERED, re #13 MOTION for Pro Hac Vice Appearance of Attorney Steven M. Coyle and Nicholas A. Geiger of Cantor Colburn LLP, filed by Cipla USA, Inc., InvaGen Pharmaceuticals, Inc.. Signed by Judge Richard G. Andrews on 3/19/2019. (nms)
March 18, 2019 Filing 12 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Cipla Limited for Cipla USA, Inc. filed by Cipla USA, Inc.. (Moore, David)
March 18, 2019 Filing 11 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Cipla Limited for InvaGen Pharmaceuticals, Inc. filed by InvaGen Pharmaceuticals, Inc.. (Moore, David)
March 18, 2019 Filing 10 ANSWER to #1 Complaint, Defenses, and, COUNTERCLAIM against Genentech, Inc., InterMune, Inc. by InvaGen Pharmaceuticals, Inc., Cipla USA, Inc..(Moore, David)
March 8, 2019 Pro Hac Vice Attorneys Ryan Hagglund, Warren K. MacRae, and Mark E. Waddell for Genentech, Inc. and InterMune, Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. Associated Cases: 1:19-cv-00078-RGA et al.(ddp)
February 25, 2019 Opinion or Order SO ORDERED, re #9 STIPULATION TO EXTEND TIME to Answer Complaint to March 18, 2019 (*Reset Answer Deadlines: Cipla USA, Inc. answer due 3/18/2019; InvaGen Pharmaceuticals, Inc. answer due 3/18/2019). Signed by Judge Richard G. Andrews on 2/25/2019. (nms)
February 22, 2019 Filing 9 STIPULATION TO EXTEND TIME to Answer Complaint to March 18, 2019 - filed by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen)
February 12, 2019 Opinion or Order SO ORDERED, re (11 in 19-cv-78-RGA, 8 in 19-cv-154-RGA, 7 in 19-cv-202-RGA, 8 in 19-cv-130-RGA, 9 in 19-cv-103-RGA, 9 in 19-cv-110-RGA, 9 in 19-cv-123-RGA, 8 in 19-cv-205-RGA, 8 in 19-cv-219-RGA, 10 in 19-cv-178-RGA, 13 in 19-cv-131-RGA, 7 in 19-cv-223-RGA, 7 in 19-cv-142-RGA, 7 in 19-cv-136-RGA, 11 in 19-cv-104-RGA, 8 in 19-cv-190-RGA, 7 in 19-cv-141-RGA, 8 in 19-cv-177-RGA, 13 in 19-cv-132-RGA, 9 in 1:19-cv-00120-RGA, 8 in 19-cv-111-RGA, 8 in 19-cv-195-RGA, 9 in 19-cv-105-RGA, 9 in 1:19-cv-00109-RGA, 7 in 19-cv-203-RGA, 10 in 19-cv-164-RGA) MOTION for Pro Hac Vice Appearance of Attorney Mark E. Waddell, Warren K. MacRae and Ryan Hagglund of LOEB & LOEB LLP filed by Genentech, Inc., InterMune, Inc.. Signed by Judge Richard G. Andrews on 2/12/2019. Associated Cases: 1:19-cv-00078-RGA et al.(nms)
February 11, 2019 Filing 8 MOTION for Pro Hac Vice Appearance of Attorney Mark E. Waddell, Warren K. MacRae and Ryan Hagglund of LOEB & LOEB LLP - filed by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen)
February 6, 2019 Filing 7 AFFIDAVIT of Service for Complaint and related papers served on InvaGen Pharmaceuticals, Inc. on February 5, 2019, filed by Genentech, Inc., InterMune, Inc.. (Jacobs, Karen)
February 6, 2019 Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:19-cv-00177-RGA, 1:19-cv-00178-RGA, 1:19-cv-00190-RGA, 1:19-cv-00195-RGA, 1:19-cv-00202-RGA, 1:19-cv-00203-RGA, 1:19-cv-00205-RGA, 1:19-cv-00219-RGA, 1:19-cv-00223-RGA (rjb)
February 4, 2019 Filing 6 Return of Service Executed by InterMune, Inc., Genentech, Inc.. Cipla USA, Inc. served on 2/4/2019, answer due 2/25/2019. (Jacobs, Karen)
February 1, 2019 Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Roche Holding Ltd., Corporate Parent Novartis Ltd., Corporate Parent Roche Holdings, Inc. for Genentech, Inc. filed by Genentech, Inc. (rwc)
February 1, 2019 Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,566,729 B1 ;7,635,707 B1 ;7,767,700 B2 ;7,816,383 B1 ;7,910,610 B1. (rwc)
February 1, 2019 Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 12/22/18. Date of Expiration of Patent: 9/22/26 through 8/30/33.Thirty Month Stay Deadline: 4/15/2022. (rwc)
February 1, 2019 Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (rwc)
February 1, 2019 Filing 1 COMPLAINT FOR PATENT INFRINGEMENT - filed against Cipla Limited, Cipla USA, Inc., InvaGen Pharmaceuticals, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 400, receipt number 0311-2559814.) - filed by InterMune, Inc., Genentech, Inc. (Attachments: #1 Exhibit 1-15, #2 Civil Cover Sheet)(rwc)
February 1, 2019 Summons Issued with Magistrate Consent Notice attached as to Cipla Limited on 2/1/2019; Cipla USA, Inc. on 2/1/2019; InvaGen Pharmaceuticals, Inc. on 2/1/2019. Requesting party or attorney should pick up issued summons at the Help Desk, Room 4209, or call 302-573-6170 and ask the Clerk to mail the summons to them. (rwc)

Access additional case information on PACER

Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.

Access this case on the Delaware District Court's Electronic Court Filings (ECF) System

Search for this case: Genentech, Inc. et al v. InvaGen Pharmaceuticals, Inc., et al.
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Web [ Unicourt | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: Genentech, Inc.
Represented By: Karen Jacobs
Represented By: Jack B. Blumenfeld
Represented By: Ryan Hagglund
Represented By: Mark E. Waddell
Represented By: Warren K. MacRae
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Plaintiff: InterMune, Inc.
Represented By: Karen Jacobs
Represented By: Jack B. Blumenfeld
Represented By: Ryan Hagglund
Represented By: Mark E. Waddell
Represented By: Warren K. MacRae
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Cipla Limited
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: InvaGen Pharmaceuticals, Inc.
Represented By: Steven M. Coyle
Represented By: Nicholas A. Geiger
Represented By: David Ellis Moore
Represented By: Bindu Ann George Palapura
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]
Defendant: Cipla USA, Inc.
Represented By: Steven M. Coyle
Represented By: Nicholas A. Geiger
Represented By: David Ellis Moore
Represented By: Bindu Ann George Palapura
Search News [ Google News | Marketwatch | Wall Street Journal | Financial Times | New York Times ]
Search Finance [ Google Finance | Yahoo Finance | Hoovers | SEC Edgar Filings ]
Search Web [ Unicourt | Justia Dockets | Legal Web | Google | Bing | Yahoo | Ask ]

Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.


Why Is My Information Online?